Biotech firms leaving big US cities for the suburbs
High rents, tight lab space forcing them out of Boston, New York and San Francisco
New York
THE biotech industry is facing high rents and tight lab space in Boston, New York and San Francisco, forcing companies into the suburbs in a sign that the "live, work and play" movement into big cities may have hit a roadblock.
For example, Modern Meadow, a biotech startup poised to manufacture leather from the fermentation of natural collagen protein without using live animals, was looking at a prohibitive US$200 million cost to build its own lab and manufacturing facility in New York City.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Property
Hong Kong home prices rise for first time in 11 months after curbs scrapped
HDB resale prices accelerate, rising 1.8% in Q1 on stronger demand
Singapore’s private home prices up 1.4% in Q1, rents drop by 1.9%: URA
OUE wins tender to lease, develop new ‘zero-energy’ hotel at Changi Airport’s T2
Singapore office rents in central region fall 1.7 per cent in Q1 over Q4: URA
Homebuyers shun new real estate in Vancouver, hurting builders